title: Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo.
abstract: Low-dose oral tetrahydrocannabinol (THC) reduces progression of atherosclerosis in mice. THC activates central cannabinoid-1 receptors (CB1) with subsequent psychoactive effects as well as peripheral cannabinoid-2 receptors (CB2). In order to dissect the underlying mechanisms, we performed experiments under selective CB2 stimulation as well as after genetic disruption of the CB2 receptor. Atherosclerosis prone apolipoprotein E-deficient mice were crossed with cannabinoid receptor-2 deficient mice to obtain ApoE -/- CB2 -/- double knockout mice. After 8weeks of a high-cholesterol diet, immunohistochemical stainings of the aortic root revealed that vascular leukocyte infiltration in atherosclerotic plaques was accelerated in ApoE -/- CB2 -/- mice compared with ApoE -/- mice. This was accompanied by increased release of reactive oxygen species as measured using L012-enhanced chemiluminescence, and by decreased endothelial function as assessed in isolated aortic rings in organ chamber experiments. ApoE -/- mice treated with the selective CB2 agonist JWH 133 during a high-cholesterol diet showed decreased atherosclerotic lesion formation, improved endothelial function and reduced levels of reactive oxygen species. To assess whether CB2 expression in circulating cells influences atherosclerosis, irradiated ApoE -/- mice were repopulated with bone marrow-derived cells from ApoE -/- and ApoE -/- CB2 -/- mice and were fed a high-cholesterol diet for 8weeks. CB2 deficiency in bone marrow-derived cells increased leukocyte infiltration into the vessel wall, but had no impact on plaque formation. Cell culture experiments revealed that CB2 activation diminishes ROS generation in vascular cells. Selective CB2 receptor stimulation modulates atherogenesis via impact on both circulating proinflammatory and vascular cells.
authors: Department for Cardiology, University of Bonn, Germany. felix.hoyer@ukb.uni-bonn.de
authors: Friedrich Felix
authors: FF
authors: Hoyer
authors: Martin
authors: M
authors: Steinmetz
authors: Sebastian
authors: S
authors: Zimmer
authors: Astrid
authors: A
authors: Becker
authors: Dieter
authors: D
authors: Lütjohann
authors: Rainer
authors: R
authors: Buchalla
authors: Andreas
authors: A
authors: Zimmer
authors: Georg
authors: G
authors: Nickenig
mesh_terms: D000818:Animals; D001057:Apolipoproteins E / Q000235:genetics; D050197:Atherosclerosis / Q000378:metabolism* / Q000473:pathology / Q000517:prevention & control; D001794:Blood Pressure; D016026:Bone Marrow Transplantation; D063385:Cannabinoid Receptor Modulators / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D042783:Endothelial Cells / Q000378:metabolism; D004727:Endothelium / Q000378:metabolism; D006339:Heart Rate; D007962:Leukocytes / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D017382:Reactive Oxygen Species / Q000378:metabolism; D043885:Receptor, Cannabinoid, CB2 / Q000235:genetics / Q000378:metabolism*
chemical_list: D001057:Apolipoproteins E; D063385:Cannabinoid Receptor Modulators; D017382:Reactive Oxygen Species; D043885:Receptor, Cannabinoid, CB2; D002784:Cholesterol